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PENILAIAN SIFAT FIZIKO-KIMIA DAN KESAN SIMEN ACCELERATED 
PORTLAND BERASASKAN KITOSAN TERHADAP SEL TUNJANG 
DARIPADA GIGI SUSU MANUSIA YANG TERLUPAS 
ABSTRAK 
Kemajuan dalam bidang endodontik seperti teknik, peralatan dan bahan telah 
meningkatkan penjagaan kesihatan mulut dan menjadikan rawatan pergigian lebih 
berkesan, serta menjimatkan kos dan masa. Accelerated Portland simen (APC) adalah 
bahan berpotensi dengan sifat kimia, fizikal dan biologi yang baik. Ia telah dikaji 
sebagai bahan alternatif untuk mengatasi kelemahan utama mineral trioksida agregat 
(MTA) dan simen portland (PC) seperti tempoh pengerasan dan kos yang tinggi. 
Chitosan (CT) juga telah digunakan dalam banyak aplikasi perubatan kerana 
kepelbagaian sifat biologinya. Dalam kajian ini, APC disediakan dalam kombinasi 
dengan CT dan dinamakan APC-CT. Kajian ini bertujuan menilai sifat kimia, fizikal 
dan mekanikal APC-CT dan kesannya terhadap kebioserasian, pemineralan dan 
potensi pembezaan dentinogenik/osteogenik sel tunjang dari gigi susu manusia yang 
terlupas (SHED). APC-CT disediakan dengan pelbagai kepekatan larutan CT 
(0.625%-, 1.25%- dan 2.5%) dan APC telah digunakan sebagai kawalan. Sifat kimia 
dinilai menggunakan FTIR dan FESEM/EDX selain sifat fizikal dan mekanikal seperti 
masa pengerasan, kekuatan mampatan, kekerasan mikro permukaan, pH dan 
keterlarutan. Kemudian, kesan ekstrak APC-CT terhadap kebolehhidupan, pelekatan 
sel dan apoptosis juga dinilai. Aktiviti pemineralan SHED dinilai oleh pewarnaan 
merah Alizarin dan Von Kossa. Akhirnya, pembezaan dentinogenik/osteogenik SHED 
dianalisis dengan menilai pengekspresan gen penanda dentinogenik/osteogenik 
terpilih iaitu DSPP, MEPE, DMP-1, OPN, OCN, OPG, RANKL, RUNX2, ALP dan 
COL1A1 dengan “real-time PCR”. Hasil kajian FTIR yang disahkan menunjukkan 
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kehadiran hablur halus CT yang tersebar dan mengisi ruang struktur APC 
menghasilkan fasa yang lebih homogen. Komposisi kimia APC dan APC-CT adalah 
hampir sama dengan kehadiran O, C dan Si yang lebih tinggi dalam APC-CT. Julat 
nilai tempoh pengerasan, kekuatan mampatan, kekerasan mikro, pH dan keterlarutan 
adalah di antara 46.6-48.5 min, 51.3-39.1 MPa, 44.89-38.57 HV, 11.02-11.04 (24 jam) 
dan 3.23-2.44%. CT meningkatkan pH dan keterlarutan APC dan memanjangkan 
tempoh pengerasannya. Walau bagaimanapun, kekuatan mampatan berkurang dan 
memberi kesan minimum terhadap kekerasan mikro, Ujian kesitotoksikan 
menunjukkan bahawa APC-CT menyokong proliferasi dan interaksi SHED terhadap 
bahan tersebut; serta tidak menunjukkan kesan apoptosis. Pewarnaan merah Alizarin 
dan Von Kossa menunjukkan peningkatan aktiviti pemineralan SHED apabila dirawat 
dengan APC-CT. Pengekspresan gen penanda DSPP, MEPE, DMP-1, OPN, OCN, 
OPG dan RANKL meningkat dalam SHED yang dirawat APC-CT. Sementara itu, 
pengekspresan gen penanda RUNX2, ALP dan COL1A1 berkurang. Penemuan ini 
menunjukkan bahawa APC-CT memperlihatkan sifat kimia, fizikal dan mekanikal 
yang baik. APC-CT adalah tidak toksik dan menggalakkan pembezaan 
dentinogenik/osteogenik dan aktiviti pemineralan; ini menunjukkan potensi aplikasi 








PHYSICO-CHEMICAL PROPERTIES AND EFFECTS OF CHITOSAN-
BASED ACCELERATED PORTLAND CEMENT ON STEM CELLS FROM 
HUMAN EXFOLIATED DECIDUOUS TEETH 
ABSTRACT 
Advancement in the field of endodontic such as techniques, instrumentations 
and materials have considerably improved the oral health care and have made the 
dental treatment more efficient, as well as cost and time effective. Accelerated Portland 
cement (APC) is a potential material with favourable chemical, physical and biological 
properties. It was studied as an alternative material to overcome the major limitations 
of mineral trioxide aggregate (MTA) and portland cement (PC) such as delayed setting 
time and high cost of MTA. Chitosan (CT) has also been used in numerous medical 
applications due to its various biological properties. In this study, APC was prepared 
in combination with CT and designated as APC-CT. This study aimed to evaluate the 
chemical, physical and mechanical properties of APC-CT and to evaluate its 
biocompatibility, mineralization activity and dentinogenic/osteogenic differentiation 
potential on stem cells from human exfoliated deciduous teeth (SHED). APC-CT was 
prepared with various CT concentrations of 0.625%-, 1.25%- and 2.5%-CT solutions, 
and APC was used as control. The chemical characterizations by FTIR and 
FESEM/EDX were evaluated, in addition to the physical and mechanical properties 
such as setting time, compressive strength, surface microhardness, pH and solubility. 
Then, the effect of APC-CT on cell viability, attachment and apoptosis were assessed. 
The mineralization activity of SHED was evaluated by Alizarin Red staining and Von 
Kossa stain. Finally, the dentinogenic/osteogenic differentiation of SHED was 
analysed by evaluating the gene expression of selected dentinogenic/osteogenic 
markers i.e. DSPP, MEPE, DMP-1, OPN, OCN, OPG, RANKL, RUNX2, ALP and 
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COL1A1 by real-time PCR. The results confirmed the interaction of CT with APC by 
FTIR spectra. The surface morphology of APC-CT was characterized by the presence 
of CT crystallites which spread and filled the spaces in APC structure that resulted in 
more homogeneous phases. The chemical compositions of APC and APC-CT were 
almost identical with intensified O, C and Si in APC-CT. The setting time, 
compressive strength, microhardness, pH and solubility obtained ranged between 
46.6-48.5 min, 51.3-39.1 MPa, 44.89-38.57 HV, 11.04-11.02 (24 hrs) and 3.23-2.44%, 
respectively. CT improved the pH and solubility of APC and extended its setting times. 
However, compressive strengths were reduced and minimum effect on microhardness 
was observed. Cytotoxicity assays demonstrated that APC-CT supported the cell 
proliferation and interaction of SHED to the materials; as well as no apoptotic effect 
was observed. Alizarin Red and Von Kossa stainings demonstrated increased 
mineralization activity of SHED when treated with APC-CT. The expressions of 
DSPP, MEPE, DMP-1, OPN, OCN, OPG and RANKL markers were up-regulated in 
APC-CT-treated SHED. While, the expressions of RUNX2, ALP and COL1A1 markers 
were down-regulated. These findings demonstrate that APC-CT exhibits good 
chemical, physical and mechanical properties. APC-CT is non-toxic and promotes 
dentinogenic/osteogenic differentiation and mineralization activity; which provides 
potential applications of APC-CT in tooth/bone tissue engineering.  
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CHAPTER 1  
 
INTRODUCTION 
1.1 Background of the study 
Advancement in the field of endodontic such as techniques, instrumentations and 
materials have considerably changed the quality of dental treatment. These 
advancements have improved the oral health care and have made the dental treatment 
more reliable, predictable, as well as more cost and time effective (Lababidi, 2013). 
 
The progress in the field of regenerative materials has significantly highlighted on the 
research in tooth mineralization and biological behaviour of the dentin-pulp complex. 
Dentin-pulp complex has the ability to adapt with the stimuli invoking defence 
responses to preserve the tooth vitality. The main function of dental pulp is to secrete 
dentin during tooth development and maintain self-protection by reinitiating 
dentinogenesis when exposed to the external injuries. The concept of vital pulp therapy 
involves the process and procedure which aim to maintain the pulp vitality. The 
technique is based on biological approach where more focus on the understanding of 
patho-physiological processes of dentin-pulp complex. This concept is applied in the 
research and studies on the development of new materials which simulate the 
physiological factors of restored tissues (Akhlaghi and Khademi, 2015).  
   
In dental treatment, a tissue response to injuries involves complex cellular and 
molecular biological process which result in tissue repair or regeneration (Lin and 
Rosenberg, 2011). Treatment of the endodontic diseases such as irreversible pulpitis 
or apical periodontitis involves wound healing by tissue repair or combination of tissue 
repair and regeneration (Lin and Rosenberg, 2011). In indirect pulp capping treatment, 
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the application of a potential material can induce a reactionary dentinogenesis by 
stimulating the surviving primary odontoblast and the release of growth factors from 
dentin matrix (Song et al., 2017a; Tomson et al., 2017). Whereas, in direct pulp 
capping, pulpotomy and apexogenesis, the application of the material can induce the 
dentin bridge formation by stimulating a reparative dentinogenesis through the 
recruitment and differentiation of progenitor/stem cells in pulp into odontoblast-like 
cells and the release of growth factors from the dentin matrix (Chogle et al., 2012; 
Tomson et al., 2017). Moreover, in periapical wound healing, the progenitor/stem cells 
are recruited and differentiated into PDL fibroblasts, cementoblast-like cells and 
osteoblasts to form PDL ligament, cementum and alveolar bone, respectively (Han et 
al., 2014). A regenerative healing with some fibrosis of the periapical tissue is induced 
after surgical and nonsurgical endodontic treatments. In apexification, the formed 
calcified barrier at the blunt open apex was described as cementum-like tissue or 
osteodentin (Lin and Rosenberg, 2011). 
 
The introduction of mineral trioxide aggregate (MTA) is one of great advancement in 
endodontic. MTA is a portland cement-based material which was introduced in an 
endodontic field in the year 1993. The material was used for root end filling and root 
perforation repair (Lee et al., 1993; Torabinejad et al., 1993). Several studies have 
demonstrated that MTA shows good physico-chemical, mechanical and biological 
properties (Asgary et al., 2012; Kim et al., 2013; Kaup et al., 2015) as well as enhances 
the mineralization activity and dentinogenic/osteogenic cell differentiation (Wang et 
al., 2014b; Yan et al., 2014; Saberi et al., 2019). In addition, its behaviour in clinical 
applications has been widely investigated (Parirokh et al., 2018). As for the clinical 
and treatment purposes, MTA is very useful for restoring root perforations and 
3 
resorption (Ikhar et al., 2013; Yadav et al., 2013; Mente et al., 2014b), apexification 
procedure (Damle et al., 2016) and as a lining in the vital pulp therapy (Mente et al., 
2014a). However, MTA is not routinely used in the clinical practice due to the high 
cost and could be unaffordable for some patients (Foley, 2011).    
 
Therefore, current research and studies are looking for the lower cost of endodontic 
material which presenting good properties. Portland cement (PC) is made from raw 
materials which are low cost and widespread-available around the world such as 
limestone, clay minerals, sand, iron minerals and gypsum (Fernández-Carrasco et al., 
2012), which make the PC very cost-effective and affordable cement. PC is the main 
ingredient of MTA, both materials have a similar composition, except the presence of 
bismuth oxide in MTA. PC has similar physico-chemical and mechanical properties to 
MTA and it has been suggested as an available substitute to MTA due to its low cost 
and economically affordable (Islam et al., 2006; Khan et al., 2016).   
 
The similarity in chemical composition and physical properties between white MTA 
(WMTA) and white PC (WPC) attracted the interest in evaluating the WPC as a 
clinical alternative to WMTA (Islam et al., 2006; Khan et al., 2016). The experimental 
studies, animal models and reported cases revealed that the favourable biological 
profile and good sealing ability of WPC are similar to that of WMTA (Al-Hezaimi et 
al., 2011; Shahi et al., 2011; Bidar et al., 2014; Yildirim et al., 2016a). In addition, the 
literature provided insight on the similarity between WPC and MTA in term of 
antibacterial activities (Tanomaru et al., 2014) and amount of arsenic released from 
both materials (Duarte et al., 2005). Furthermore, WPC demonstrated similar results 
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to MTA in preventing microleakage and it was successfully used in the repair of 
perforations and as retro filling material (Shahi et al., 2011; Borges et al., 2014a). 
 
However, PC also has similar disadvantage like MTA, which is long setting time that 
results in the initial looseness of the mixture and makes the handling rather difficult 
(Torkittikul and Chaipanich, 2012). Thus, various additives were investigated as 
setting time accelerators to PC (Bost et al., 2016) including calcium chloride (CaCl2).     
   
CaCl2 significantly decreases the setting time of WPC (Torkittikul and Chaipanich, 
2012) in addition to preserving and strengthening its favourable biological properties 
(Ong et al., 2012). Accelerated portland cement (APC), where the PC was added with 
a portion of CaCl2, had showed better sealing ability and increased the release of 
calcium ions while maintaining high pH (Bortoluzzi et al., 2006a; Bortoluzzi et al., 
2006b). Furthermore, APC is non-toxic and may have potential to promote bone 
healing (Abdullah et al., 2002; Hoshyari et al., 2016).   
 
The chemical composition of WPC from different countries of origin has been 
examined such as Egypt, Malaysia (Ahmed et al., 2016), Korea (Hwang et al., 2011), 
Thailand (Torkittikul and Chaipanich, 2012) and United Kingdom (Camilleri et al., 
2012). The Malaysian accelerated WPC has been reported by Ong et al. (2012) to 
exhibit a favourable cell viability comparable to that of accelerated MTA. Thus, it may 
be considered that the Malaysian accelerated WPC has the potential to be used as an 
alternative to the MTA since it will be more cost effective and affordable for dental 
applications.   
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In order to improve the properties of APC as an endodontic material and to overcome 
the undesirable characteristics, a modification to its chemical composition was made 
in this study by incorporating chitosan (CT).  
 
CT is a natural biopolymer originated from chitin. It has been used in numerous 
medical applications due to its favourable properties such as biodegradable, 
biocompatible, non-toxic and possesses antimicrobial activity (Bano et al., 2017). In 
addition, studies have demonstrated that CT improved the mechanical properties of 
cements and promoted osteogenesis (Aryaei et al., 2015; Tao et al., 2020). This 
material is also easy to manipulate, available and has natural cationic property which 
makes it suitable to be used in hydrogels (Ahmadi et al., 2015). CT-based materials 
have been given great importance in the field of material development, they have 
outstanding characteristics such as biocompatibility, dentinogenic/osteogenic 
potential and formability into various structures (Hu et al., 2020; Islam et al., 2020). 
Hence, adding CT into APC may improve its properties by enhancing the 
biocompatibility, cell differentiation potential and mineralization activity while 
maintaining the physical and mechanical behaviours which would expand its possible 
applications. Therefore, a new bioactive material synthesized from combination of 
APC and CT was developed in the present study.   
 
Biological testing of the newly synthesized endodontic material by using stem cells 
from dental pulp is a necessary first step prior to the introduction of such material for 
examination in vivo. Stem cells from human exfoliated deciduous teeth (SHED) are 
unique unspecialized cells originated from dental pulp tissue and have the capacity of 
extensive proliferation and multipotential differentiation. For dentin and bone tissue 
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regeneration, SHED were shown to differentiate into odontoblast and osteoblast cells 
and had the ability to induce dentin and bone formation in vivo (Miura et al., 2003; 
Yamaza et al., 2010). Thus, SHED were selected in this study to assess the cytotoxic 
and differentiation potential of the newly synthesized material. 
1.2 Problem statement  
MTA could be the closest to the ideal reparative material due to its excellent properties, 
and it is considered a gold-standard material for a variety of clinical applications. 
Despite its desirable properties over the conventional restorative materials, MTA is 
very expensive which restrict its availability and distribution among the dental 
practitioners. In addition, MTA has slow setting time which makes the handling rather 
difficult and necessitates a multiple-visit before completing the treatment (Foley, 
2011; Tanalp et al., 2012; Kang et al., 2015; Mostafa and Moussa, 2018). These 
aforementioned drawbacks limit the use of MTA in its full potential. Thus, it will be 
of value to synthesize an alternative material with a shorter setting time and lower cost 
than MTA.  
 
Interestingly, a number of studies have investigated the potential of APC for dental 
applications as a low cost and affordable material with shorter setting time   (Bortoluzzi 
et al., 2009; Ong et al., 2012; Ahmed et al., 2016). Studies also reported the ability of 
CT to improve the mechanical properties of cements and to promote the osteogenesis 
in vivo (Rakkiettiwong et al., 2011; Aryaei et al., 2015). However, the development 
and evaluation of a material consists of APC and CT for endodontic applications have 
not yet been explored. 
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1.3 Justification of the study 
Various materials have been used for endodontic therapies such as calcium hydroxide 
(Ca(OH)2) and MTA. However, Ca(OH)2 exhibits some limitations such as poor 
quality of the formed dentinal bridge and lack of hermitic seal (Cox et al., 1996). As 
for the MTA, the drawbacks are mainly due to the high cost, tooth discoloration, 
prolonged setting time and poor handling of the material (Parirokh and Torabinejad, 
2010a; Tanalp et al., 2012). Therefore, the endodontic therapies such as repair of 
perforations and resorption defects, vital pulp therapy and apexification might be 
considered controversial by the clinicians as that the usage of this material requires 
special training and the high cost restricts its routinely clinical use (Tanalp et al., 
2012). In addition, the prolonged setting time makes the handling rather difficult and 
increases the possibility of washout (Choi et al., 2013) as well as the tooth colour 
change by MTA limits its application in aesthetic zone such as anterior teeth (Belobrov 
and Parashos, 2011). 
 
A recent new knowledge about the cellular and molecular basis of the inflammatory 
and repair processes of the pulp (Sangwan et al., 2013; Goldberg et al., 2015; Paula et 
al., 2020), and the advent of modern pharmacologic and bioengineering strategies such 
as drug delivery systems, have created many avenues for development of improved 
and predictable treatment methods for endodontic treatment. To the best of our 
knowledge, this is the first research that has been performed to synthesize and evaluate 
a material comprises of APC and CT for the endodontic application. 
 
Since APC can solve one of the main drawbacks of PC which is long setting time by 
adding CaCl2 (Torkittikul and Chaipanich, 2012), in addition to its cost-effective, 
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biocompatibility (Hoshyari et al., 2016) and favourable physico-chemical and 
biological properties (Abdullah et al., 2002; Ong et al., 2012; Torkittikul and 
Chaipanich, 2012), it seems that APC can be used as a substitute to PC and MTA in 
dental applications. CT is biocompatible, biodegradable, polycationic, promotes 
tissues regeneration (Sultankulov et al., 2019) and has potent antimicrobial activity 
against various microorganisms (DaSilva et al., 2013) and anti-inflammatory efficacy 
(Fasolino et al., 2019). 
 
In light of the above-mentioned properties, a new bioactive material comprises of 
biocompatible APC together with the component of CT was synthesized in this study 
and evaluated as an endodontic material hypothesizing that the synthesized material 
will exhibit good physico-chemical properties and be able to regenerate the dentin and 
bone through its dentinogenic/osteogenic differentiation potential. The results of this 
study will provide insights into the use of chitosan-based accelerated portland cement 
(APC-CT) as an effective, low-cost and affordable endodontic material.  
1.4 Research questions 
1. What are the chemical properties of APC-CT material?  
2. What are the physical and mechanical properties of APC-CT material? 
3. Is APC-CT material biocompatible to SHED? 
4. Does APC-CT material promote mineralization activity in SHED? 
5. Does APC-CT material promote dentinogenic/osteogenic genes expression in 
SHED?  
9 
1.5 Research hypotheses 
1. APC-CT material exhibits acceptable chemical properties. 
2. APC-CT material exhibits acceptable physical and mechanical properties.  
3. APC-CT material exhibits no cytotoxic effect on SHED. 
4. APC-CT material promotes mineralization activity in SHED.  
5. APC-CT material promotes dentinogenic/osteogenic genes expression in SHED. 
1.6 Objectives 
1.6.1 General objective 
The general aim was to study the physico-chemical and mechanical properties of a 
chitosan-based accelerated portland cement (APC-CT) material and to evaluate its 
biocompatibility and dentinogenic/osteogenic differentiation potential on stem cells 
from human exfoliated deciduous teeth (SHED). 
1.6.2 Specific objectives 
1. To characterize the synthesized APC-CT material by FTIR, FESEM and EDX.  
2. To evaluate the physical and mechanical properties of APC-CT material such as 
setting time, compressive strength, surface microhardness, pH and solubility.  
3. To evaluate the biocompatibility of APC-CT material on SHED (cell viability, 
attachment and apoptosis). 
4. To assess the effect of APC-CT material on mineralization activity of SHED. 
5. To investigate the effect of APC-CT material on dentinogenic/osteogenic potential 
in SHED. 
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CHAPTER 2  
 
LITERATURE REVIEW 
2.1 An overview of tooth development  
The same genetic and molecular mechanisms, which take place during tooth 
development, also occur during the reparative processes after carious or traumatic 
injuries (Mitsiadis and Rahiotis, 2004). Therefore, it is important to know the 
biological interactions during the dental development in order to have better 
understanding on the regenerative potential of dentin-pulp complex.  
  
Embryologically, tooth development is formed by a series of interactions between the 
oral epithelium and the neural crest ectomesenchyme (Murphy et al., 2019). Tooth 
formation is initiated by signals provided by the oral epithelium followed by the 
proliferation and projection of the epithelial cell into the underlying neural crest 
ectomesenchyme to form the dental lamina. The aggregation of these cells is known 
as a tooth bud (tooth germ), which gets pronounced to the cap shape and then to bell 
shape forming the enamel organ (EO). The EO is made up of the outer enamel 
epithelium (OEE), inner enamel epithelium (IEE), stellate reticulum (SR) and stratum 
intermedium (SI). The IEE cells differentiate into the pre-ameloblasts cells that 
become ameloblasts and lay down the future enamel (Chiba et al., 2019).  
 
The condensing mass of ectomesenchyme beneath this cap is called dental papilla 
(DP), which was differentiated by the influence of pre-ameloblasts into two types of 
cells; the odontoblasts which form the outer cell layer to secret the dentin and “non-
neural crest” derived cells which form the central zone of cells to produce the 
primordium of the pulp (Linde and Goldberg, 1993; Chai et al., 2000) (Figure 2.1). 
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Figure 2.1: Modified images of tooth bud from Ten Cate’s Oral Histology (Nanci, 
2017). The tooth bud consists of enamel organ, dental papilla and dental follicle. Four 
cell types are yielded from the differentiation of the enamel organ: OEE, SR, SI and 
IEE. The OEE and IEE oppose each other forming the cervical loop and grow apically 














The remaining mesenchymal tissue surrounds the EO to form the dental follicle. The 
cervical loop is formed apically at the region where the OEE opposes the IEE and gives 
rise to two cell layers known as epithelial root sheath of Hertwig’s, which starts the 
formation of the root and determines its shape. Then, a differentiation of the 
mesenchyme cells of the dental papilla into odontoblasts occurs to produce the root 
dentin and also a differentiation of the mesenchyme cells of the dental follicle into 
cementoblasts, fibroblast and osteoblast occurs to form cementum, periodontal 
ligaments and alveolar bone, respectively (Ohshima, 2008) (Figure 2.2). The 
membrane which separates the EO and the dental papilla becomes the site for the future 
dentino-enamel junction (DEJ) (Figure 2.3). 
 
A number of signalling factors were involved in the process of embryonic tooth 
development such as initiation, proliferation, cytodifferentiation, distribution and 
morphogenesis of the cells. These factors consist of transforming growth factor (TGF), 
epidermal growth factor (EGF), fibroblast growth factor (FGF) and bone 
morphogenetic protein (BMP) (Puthiyaveetil et al., 2016). BMP family belongs to the 
TGFβ superfamily. BMP is the key factor in the differentiation of odontoblast and 
ameloblast as it is involved in communication and signalling between the epithelium 
and mesenchyme (Liu et al., 2016). 
2.2 Pulp-dentin complex 
The dental pulp has a similar embryonic origin of dentin; both stay in close relationship 
for the whole life cycle maintaining the integrity of tooth function and shape. This 





Figure 2.2: Modified images of tooth crown and root formation from Ten Cate’s Oral 
Histology (Nanci, 2017). (A) Crown formation: At 1 Acellular zone separates the 
epithelium from the dental papilla. At 2 Elongation of cells at the inner enamel 
epithelium and elimination of the acellular zone due to the differentiation of the 
odontoblasts. At 3 Odontoblast movement toward the pulp leaving behind the 
produced dentin. At 4 Movement of ameloblasts outward leaving behind the produced 
enamel. (B, C) Root formation: Root formation occurs as a result of extension of the 
IEE and OEE in the cervical loop forming epithelial root sheath of Hertwig’s, which 
induce the odontoblast differentiation from radicular pulp to form the root dentin. 
 




Figure 2.3: A summary of human tooth formation showing tooth germ derivatives and 















2.3 Dental pulp  
Dental pulp is the central portion of the tooth comprising of loose specialized 
connective tissue and encased by dentin. The pulp has ground substance, nerves, blood 
and lymph vessels and a number of cell types mainly fibroblasts (which form the fibers 
in the pulp) and others such as odontoblasts, blood cells, undifferentiated 
mesenchymal cells, schwann cells, endothelial cells, and inflammatory and immune 
reactions cells (Sharma et al., 2010; Nanci, 2017). 
 
The pulp consists of four different parts: (1) external layer which contains the 
odontoblast cells, (2) cell-free zone, a rich part of extracellular matrix and containing 
the nerves fibers terminal, fibroblasts cytoplasmic processes and capillary plexus, (3) 
cell-rich zone, made up of undifferentiated stem/progenitor cells and (4) inner layer 
which contains the collagen fibers, nervous and vascular plexus (D’Aquino et al., 
2008; Nanci, 2017) (Figure 2.4). The pulp is connected with the surrounding tissues 
via the apical foramen at the root apex. The foramen acts as a pathway for the blood 
vessels and lymph drainages supply into the pulp and vice versa (Nanci, 2017). The 
main function of the dental pulp is to form the dentin and maintain its vitality. The 
pulp supplies the dentin with the oxygen and nutrition and contains responsive sensory 
nervous system which detects unhealthy stimuli that is inflicted by microbial invasion, 
chemical irritation and mechanical trauma (Huang, 2009).  
2.3.1 Odontoblasts 
Odontoblasts are highly specialized and differentiated cells of about 50 µm in length. 
These cells originate from the neural crest and secrete the predentin and future dentin 





Figure 2.4: Modified photomicrograph of the pulp-dentin complex from Ten Cate’s 
Oral Histology (Nanci, 2017). The image shows the odontoblast layer, cell-free zone, 























Odontoblasts form a layer at the inner surface of dentin lining the periphery of the pulp 
called “pulpo-dentinal membrane”. Mature odontoblasts have long and polarized cell 
morphology consists of a large nucleus located at the basal portion toward the pulp, 
and also the presence of golgi apparatus, endoplasmic reticulum and numerous 
mitochondria. In addition, several nucleoli and dispersed chromatin are located in the 
nucleus (Nanci, 2017). 
 
The odontoblast cell is characterized by two portions, the cell body and odontoblastic 
process. The cell body which involved in the synthesis of dentin extracellular matrix 
is located outside the predentin/dentin layer at the pulp periphery. Whereas, the 
odontoblstic process which involved in secretion of extracellular matrix molecules is 
located inside the dentin tubules crossing the predentin (MacDougall and Javed, 2010). 
(Figure 2.5). The collagen and proteoglycans molecules of the extracellular matrix are 
secreted in the predentin, while other biomineralization molecules of the extracellular 
matrix are secreted near the mineralization front (Goldberg et al., 2011).  
2.3.2 Odontoblast differentiation   
The initiation of odontoblast differentiation takes place by the interaction of pre-
odontoblast with inner dental epithelium and the effects of growth factors which 
present in close proximity to pre-odontoblasts in the basement membrane (Ruch et al., 
1995; Thesleff and Sahlberg, 1996). Growth factors are a complex of proteins in the 
extracellular matrix of the inner dental epithelium. These proteins have mitogenic 
properties and are responsible for the differentiation and polarization of the 
odontoblast (Kawashima and Okiji, 2016; Chang et al., 2019). The growth factors in 



















































The process of odontoblast differentiation occurs as; the mitotic spindles of pre-
odontoblasts align in close to the basement membrane during the last round of cell 
division. Then, the daughter cells from the pre-odontoblasts lie in contact with the 
basement membrane and elongated becoming in a polarized fashion. Subsequently, a 
cell flattening occurs making them in parallel position to the long axis of the basement 
membrane. After that, the granular endoplasmic reticular system is developed, and the 
cells become ready to secrete the predentin and then dentin components (Ruch et al., 
1995; Nanci, 2017) (Figure 2.6).  
 
The primary dental epithelium is thought to regulate the differentiation of these cells 
by controlling the cell cycles (Ruch et al., 1995). It has been determined that pre-
odontoblasts in animals must have a specific number of cell cycle to be able for 
differentiation (Holyfield et al., 2005). Nevertheless, it is not of importance in human 
cells to respond to inductive signals to start differentiation (Begue-Kirn et al., 1992). 
2.4 Dentin 
Dentin is a collagen-based mineralized connective tissue. It constitutes the main bulk 
of the tooth and is covered by the enamel in the crown portion and by cementum in the 
root portion. The dentin consists of inorganic apatite crystals embedded in the 
extracellular matrix (Goldberg et al., 2011; Orsini et al., 2012). Dentin is formed by a 
process called dentinogenesis which occurs in two steps: (1) the formation of 
collagenous network and (2) the precipitation of the inorganic mineral phase in the 




Table 2.1: Non-collagenous proteins (NCPs) in human dentin extracellular matrix. 
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Figure 2.6: Differentiation of odontoblast. (A) Undifferentiated ectomesenchymal 
cell. (B) Mitotic spindle. (C, E) daughter cells. (D) epithelial cells. (F) Differentiated 
































Tubular structures called dentinal tubules are crossing the dentin making it a permeable 
tissue, that spread from the dentino-enamel or dentino-cementum junction to the pulp. 
These tubules contain the odontoblast processes and dentinal fluid (Nanci, 2017).  
2.5 Composition of Dentin 
Seventy percent of dentin is composed of hydroxyapatite crystals, 20% of organic 
matrix and 10% of water (by weight) (Goldberg et al., 2011). The inorganic minerals 
consist of inorganic phosphate and calcium which precipitate as mineral crystals to 
mineralize the organic matrix and form mature dentin (Luz and Mano, 2010). The 
organic components of dentin mainly consist of type I collagen and non-collagenous 
proteins (NCPs). These proteins play important roles in various structural formative, 
signalling and homeostatic processes (Smith et al., 2012).  
 
Collagen, a dominant fibrous protein, is found in all connective tissues including hard 
tissues such as dentin, cementum and bone. The odontoblast cells lay down an organic 
matrix of unmineralized collagen-rich layer called as predentin which mature to dentin 
after the deposition of minerals. The collagen of the dentin is mainly type I collagen 
which forms approximately of 90% of the organic material, although trace amounts of 
type III and type V collagen have been found. NCPs in the extracellular matrix 
constituting approximately 10% of matrix (Goldberg et al., 2011; Orsini et al., 2012).    
 
NCPs are laid down from the distal part of odontoblast process. NCPs initiate and 
control the mineralization of extracellular matrix converting the predentin to dentin in 
“mineralization front” area during the dentinogenesis process (Butler, 1998). NCPs are 
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then bound to the hydroxyapatite crystals after the mineralization. NCPs in 
extracellular matrix of human dentin are summarized in Table 2.1. NCPs include: 
2.5.1 Glycoproteins 
The glycoprotein includes two groups of a small integrin-binding ligand N-linked 
glycoproteins (SIBLINGs) and a secretory calcium-binding phosphoprotein (SCPP) 
(Orsini et al., 2012). 
2.5.1(a) SIBLINGs family  
SIBLINGs family is a multibiofunctional molecules that play important functions in 
regulating a promotion and inhibition of the mineralization process of dentin and bone.  
In mineralization process, SIBLINGs serve as nucleating factors due to their highly 
acidic nature through the precipitation of calcium ions and regulation of 
hydroxyapatite crystal formation (Toyosawa et al., 2012).  
 
All the SIBLINGs share the genomic structures which are located on the human 
chromosome 4q21-23 as well as share the common gene structure features (Toyosawa 
et al., 2012). In addition, an Arg-Gly-Asp (RGD) integrin binding site which plays a 
role in adhesion and migration of cells is found in their protein (Suzuki et al., 2014). 
Major SIBLINGs in dentin tissue are dentine matrix protein-1 (DMP-1), dentine 
sialoprotein (DSP), dentine phosphoprotein (DPP), osteopontin (OPN), bone 
sialoprotein (BSP) and matrix extracellular phosphoglycoprotein (MEPE). 
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2.5.1(a)(i) Dentine matrix protein1 (DMP-1) 
DMP-1 is considered as a specific protein for dentin in spite of its expression in bone 
(Huang et al., 2008a). It was found in peritubular dentin, odontoblasts and around the 
mineralizing globules (Massa et al., 2005). DMP-1 helps in initiating the apatite 
nucleation and mineral deposition through nucleation of hydroxyapatite within the 
collagenous matrix as well as it induces odontoblast cells differentiation (Almushayt 
et al., 2006; Narayanan et al., 2006). 
2.5.1(a)(ii)  Dentin sialophosphoprotein (DSPP) 
DSPP is cleaved into three proteins after secretion; dentin sialoprotein (DSP), dentin 
glycoprotein (DGP) and dentin phosphoprotein (DPP) (Fujisawa and Tamura, 2012). 
DSPP was expressed in odontoblasts and considered as a specific protein of 
odontoblast. DSPP was also expressed in bone but with lower level of approximately 
1:400 as that in dentin (Qin et al., 2003). DSP and DPP proteins play a role in the 
regulation of hydroxyapatite nucleation onto matrix collagen and hydroxyapatite 
crystals growth (Suzuki et al., 2009) and they were identified as components of 
extracellular matrix of dentin (Yamakoshi et al., 2003). 
 
DPP, the most abundant NCPs in dentin extracellular matrix, is a cleavage product 
from C-terminal side of DSPP that contains extended triplet amino acid repeat 
sequences. It is important in biomineralization through binding to calcium and 
presenting it to collagen fibers to initiate and modulate the hydroxyapatite formation 
of dentin (Prasad et al., 2010; Fujisawa and Tamura, 2012). 
 
